Kelloff Gj

1.1k total citations
17 papers, 744 citations indexed

About

Kelloff Gj is a scholar working on Genetics, Cancer Research and Molecular Biology. According to data from OpenAlex, Kelloff Gj has authored 17 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Kelloff Gj's work include Estrogen and related hormone effects (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Cancer, Lipids, and Metabolism (2 papers). Kelloff Gj is often cited by papers focused on Estrogen and related hormone effects (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Cancer, Lipids, and Metabolism (2 papers). Kelloff Gj collaborates with scholars based in United States and Canada. Kelloff Gj's co-authors include DA Berry, NM Hylton, L. Esserman, Peter Greenwald, Marjorie Perloff, Alberts Ds, Crawford Ed, Fernand Labrie, Ronald Lieberman and Rao Kv and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Prostate Cancer and Prostatic Diseases and PubMed.

In The Last Decade

Kelloff Gj

17 papers receiving 715 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelloff Gj United States 10 270 207 194 166 118 17 744
Jeff Allen United States 13 204 0.8× 154 0.7× 87 0.4× 229 1.4× 30 0.3× 40 805
Hugh M. Pettigrew United States 9 156 0.6× 160 0.8× 68 0.4× 148 0.9× 144 1.2× 15 656
Michael Man United States 16 117 0.4× 383 1.9× 102 0.5× 343 2.1× 82 0.7× 23 1.0k
Alexei Dmitrienko United States 9 81 0.3× 160 0.8× 294 1.5× 87 0.5× 43 0.4× 25 852
Fiorella Guadagni Italy 18 149 0.6× 320 1.5× 22 0.1× 237 1.4× 67 0.6× 43 989
James Matcham United Kingdom 14 37 0.1× 218 1.1× 121 0.6× 320 1.9× 101 0.9× 26 1.3k
Connie M. Szczepanek United States 6 282 1.0× 306 1.5× 83 0.4× 238 1.4× 180 1.5× 10 1.8k
Michael Branson Switzerland 15 112 0.4× 200 1.0× 1.2k 6.1× 123 0.7× 52 0.4× 24 1.6k
Jian H. Johnson United States 12 452 1.7× 231 1.1× 18 0.1× 459 2.8× 157 1.3× 16 1.1k
Anja Henningsson Sweden 8 69 0.3× 197 1.0× 79 0.4× 567 3.4× 89 0.8× 12 889

Countries citing papers authored by Kelloff Gj

Since Specialization
Citations

This map shows the geographic impact of Kelloff Gj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelloff Gj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelloff Gj more than expected).

Fields of papers citing papers by Kelloff Gj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelloff Gj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelloff Gj. The network helps show where Kelloff Gj may publish in the future.

Co-authorship network of co-authors of Kelloff Gj

This figure shows the co-authorship network connecting the top 25 collaborators of Kelloff Gj. A scholar is included among the top collaborators of Kelloff Gj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelloff Gj. Kelloff Gj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Gj, Kelloff, et al.. (2009). I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy. Clinical Pharmacology & Therapeutics. 86(1). 97–100. 496 indexed citations
2.
Wani, Gulzar, et al.. (2002). Modulation of Ki67, p53 and RARbeta expression in normal, premalignant and malignant human oral epithelial cells by chemopreventive agents.. PubMed. 21(5). 3229–35. 4 indexed citations
3.
Gj, Kelloff, et al.. (1999). Strategies for chemoprevention of prostate cancer. Prostate Cancer and Prostatic Diseases. 2(S1). 27–33. 21 indexed citations
4.
Gj, Kelloff, et al.. (1999). Screening of potential cancer preventing chemicals as aromatase inhibitors in an in vitro assay.. PubMed. 19(2A). 1017–20. 6 indexed citations
5.
Gj, Kelloff, et al.. (1998). Endpoint markers for clinical trials of chemopreventive agents derived from the properties of epithelial precancer (intraepithelial neoplasia) measured by computer-assisted image analysis.. PubMed. 32. 133–47. 6 indexed citations
6.
Gj, Kelloff, et al.. (1998). Screening of potential cancer preventing chemicals as antioxidants in an in vitro assay.. PubMed. 18(2A). 769–73. 2 indexed citations
7.
Gj, Kelloff, et al.. (1997). Biomarker end-points in cancer chemoprevention trials.. PubMed. 273–80. 19 indexed citations
8.
Greenwald, Peter & Kelloff Gj. (1996). The role of chemoprevention in cancer control.. PubMed. 13–22. 25 indexed citations
9.
Gj, Kelloff, et al.. (1996). Strategies for identification and clinical evaluation of promising chemopreventive agents.. PubMed. 10(10). 1471–84; discussion 1484. 44 indexed citations
10.
Gj, Kelloff, et al.. (1994). Clinical development plan: N-(4-hydroxyphenyl)retinamide.. PubMed. 20. 176–96. 38 indexed citations
11.
Gj, Kelloff, et al.. (1994). Clinical development plan: 18beta-glycyrrhetinic acid.. PubMed. 20. 166–75. 3 indexed citations
12.
Gj, Kelloff, et al.. (1994). Development of surrogate endpoint biomarkers for clinical trials of cancer chemopreventive agents: relationships to fundamental properties of preinvasive (intraepithelial) neoplasia.. PubMed. 19. 10–22. 22 indexed citations
13.
Gj, Kelloff, et al.. (1994). Clinical development plan: Proscar.. PubMed. 20. 231–9. 3 indexed citations
14.
Gj, Kelloff, et al.. (1994). Clinical development plan: beta-carotene and other carotenoids.. PubMed. 20. 110–140. 4 indexed citations
15.
Gj, Kelloff, et al.. (1994). Chemoprevention of MNU-induced mammary tumorigenesis by hormone response modifiers: toremifene, RU 16117, tamoxifen, aminoglutethimide and progesterone.. PubMed. 14(3A). 889–93. 31 indexed citations
16.
Kv, Rao, et al.. (1992). Animal models for chemoprevention of respiratory cancer.. PubMed. 45–9. 9 indexed citations
17.
Gj, Kelloff, et al.. (1973). Oncogenic potential of murine C-type RNA virus passaged directly from naturally occurring tumors of the BALB-cCr mouse.. PubMed. 51(2). 621–30. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeff Allen Breakdown of academic impact, for papers by Hugh M. Pettigrew Breakdown of academic impact, for papers by Michael Man Breakdown of academic impact, for papers by Alexei Dmitrienko Breakdown of academic impact, for papers by Fiorella Guadagni Breakdown of academic impact, for papers by James Matcham Breakdown of academic impact, for papers by Connie M. Szczepanek Breakdown of academic impact, for papers by Michael Branson Breakdown of academic impact, for papers by Jian H. Johnson Breakdown of academic impact, for papers by Anja Henningsson
Rankless by CCL
2026